Nationalität
USA
Geburtsjahr
1977
Mikrobiologie an der Miami University in Oxford, Ohio, B.A.
Business Administration an der University of California, San Diego, Californien, MBA
2002-2008
Verschiedene Account / Produkt Manager Rollen bei Roche Diagnostics, USA
2008-2010
Commercial Operations Manager, Japan / APAC, Tokio
2010-2012
Director Applied Science / Director Molecular Diagnostics Taiwan, Taipei City
2012-2014
Country Manager / Director Roche Diagnostics Irland, Dublin
2014-2016
President / General Manager, Roche Pharmaceuticals Peru, Lima
2016-2018
President / General Manager Roche Pharmaceuticals Korea, Seoul
2018-2019
Vice President, Lifecycle Leader für Tecentriq Lungen-, Kopf- und Halskrebs, Genentech, USA
2019
Senior Vice-President, Head of Global Commercial Product Strategy, Gilead Sciences, Foster City, USA
2019-2022
President & CEO Roche Diagnostics Corporation North America, Indianapolis, USA
Seit Januar 2023
CEO Roche Diagnostics, F. Hoffmann-La Roche Ltd., Basel, Switzerland
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.